Position in MDGL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,947,317
+$1,180,084 QoQ
Shares Held
5,489
+62.6% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#142
of 411 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Derivatives in MDGL
reported options exposure · as of Jun 30, 2025CallValue
$4,206,696
CallShares
13,900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,706,205,847 across 455 Biotechnology names. MDGL ranks #53 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in MDGL
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,947,317 | 5,489 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,767,233 | 3,376 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $22,548,203 | 38,720 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $22,892,635 | 49,912 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $18,967,658 | 62,674 | Shares | Sole | 2026-02-27 | |
| 2025-06-30 | $4,206,696 | 13,900 | Call | Sole | 2026-02-27 | |
| 2025-03-31 | $15,525,081 | 46,871 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $16,432,278 | 53,253 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $8,548,009 | 40,279 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $4,257,311 | 15,196 | Shares | Sole | 2026-03-23 | |
| 2024-06-30 | $84,048 | 300 | Call | Sole | 2026-03-23 | |
| 2024-03-31 | $2,403,360 | 9,000 | Call | Sole | 2026-03-24 | |
| 2024-03-31 | $6,735,549 | 25,223 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $8,874,348 | 38,354 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $3,856,916 | 26,410 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $6,234,921 | 26,991 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $13,405,457 | 55,335 | Shares | Sole | 2026-03-30 | |
| 2023-03-31 | $4,263,776 | 17,600 | Call | Sole | 2026-03-30 | |
| 2022-12-31 | $25,503,686 | 87,868 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $2,821,540 | 43,415 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $546,799 | 7,639 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $913,987 | 9,315 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,241,101 | 14,646 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,477,151 | 18,513 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $1,613,206 | 16,561 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,242,079 | 19,168 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,781,943 | 16,029 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,049,516 | 17,262 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,246,539 | 19,837 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,228,249 | 18,398 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||